Company Directory / Biotechnology
PrivateFor profitBiotechnologyBruxelles, Brussels, Belgium
Univercells
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions
- Founded
- 2013 13 years ago
- Staff
- 251-500 86 on LinkedIn
- Followers
- 21k on LinkedIn
- Funding
- $262M as listed, USD
For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit.
Set against six million companies
Size
251-500 people: larger than 92% of companies with a size listed. 86 people list it on LinkedIn.
Age
13 years old.
Reach
Website ranked #6,060,478 in the world for traffic, about 1k visits a month. 21,377 followers on LinkedIn.
What it does
BiotechnologyHealth CareManufacturingBiotechnologymRNACDMOServices
Funding, as listed
$262M raised in total
- Rounds12
- LatestSeries d, Oct 2022
- Latest amountUSD 43,312,927
- Investors20, 7 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Univercells, field by field. Contact details are held but never shown.
The company
- Name
- Univercells
- Type
- For profit
- Status
- Private
- Founded
- 2013
- Founders
- Hugues Bultot, José Castillo
- Industry
- Biotechnology
- Categories
- Biotechnology, Health Care, Manufacturing
- Specialities
- Biotechnology, mRNA, CDMO, Services
Where
- City
- Bruxelles
- Region
- Brussels
- Country
- Belgium
- Markets
- European Union (EU), Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 251-500
- People on LinkedIn
- 86
- LinkedIn followers
- 21,377
- Web traffic rank
- #6,060,478
- Monthly web visits
- 1,137
Funding, as listed
- Total
- $261,718,405 USD
- Rounds
- 12
- Latest round
- Series d
- Latest round date
- Oct 2022
- Latest amount
- 43,312,927 USD
- Investors
- 20
- Lead investors
- 7
- Listing status
- private
Corporate family
- Acquisitions made
- 1
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Univercells may be growing as indicated by the acquisition by Donaldson for $148 million, which suggests a valuation that reflects the company's potential and achievements. This financial transaction demonstrates a significant investment into Univercells, implying confidence in its business model and future prospects within the biomanufacturing industry. The acquisition can also be seen as a strategic move to enhance Univercells' market position and resources, potentially leading to an expansion of operations and an increase in its capabilities.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Biotechnology in Belgium.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.